Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Size Projected To Increase From $5.79 Billion To $9.22 Billion During The Forecast Period
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Growth Potential: How Will Market Size Change Through 2030?
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market has experienced rapid expansion in recent years, with its size climbing from $5.14 billion in 2025 to $5.79 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.6%. This historical growth was driven by factors such as the limited accessibility of mRNA synthesis platforms, early-phase research into mRNA-based therapeutics, a dependence on small-scale laboratory production, the emergence of basic regulatory structures, and the significant expenses tied to purification and formulation services.
The market for messenger ribonucleic acid (mRNA) synthesis and manufacturing is projected to experience strong expansion in the years ahead. Its value is anticipated to reach $9.22 billion by 2030, reflecting a compound annual growth rate (CAGR) of 12.3%. This surge during the forecast period can be linked to progress in automated mRNA synthesis technology, the establishment of larger commercial-scale mRNA manufacturing plants, increased funding for vaccines and therapeutic development, a rising need for self-amplifying mRNA and innovative formulations, and a growth in preclinical and clinical research partnerships. Key developments shaping this period include the wider adoption of GMP-compliant mRNA production, a heightened need for large-scale mRNA manufacturing, the broadening of mRNA therapeutic and vaccine initiatives, a stronger emphasis on purification, capping, and tailing services, and the increasing use of mRNA-LNP formulations with integrated delivery systems.
Download A Free Sample Report For Comprehensive Market Insights:
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Opportunity Drivers: What Is Creating New Revenue Potential?
The growing incidence of infectious diseases is projected to boost the messenger ribonucleic acid (mRNA) synthesis and manufacturing market moving forward. Infectious diseases are illnesses triggered by pathogenic microorganisms like bacteria, viruses, fungi, or parasites, which includes conditions such as malaria that may be transmitted either directly or indirectly. This rise in infectious disease prevalence is largely attributed to rapid urbanization, which results in greater population density and close interpersonal contact, thereby facilitating the spread of infections. mRNA synthesis and manufacturing play a key role in fighting infectious diseases by allowing for the swift creation and scalable output of targeted vaccines and therapeutics designed to elicit a specific immune response. As an example, in October 2024, the World Health Organization—a Switzerland-based international public health body—reported that roughly 8.2 million people were newly diagnosed with tuberculosis in 2023, compared to about 7.5 million in 2022, making tuberculosis the leading cause of death among infectious diseases. Consequently, the increasing prevalence of infectious diseases is fueling the expansion of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market.
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Segment Breakdown: Which Categories Generate The Most Revenue?
The messenger ribonucleic acid (mrna) synthesis and manufacturing market covered in this report is segmented –
1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
2) By Scale Of Operation: Preclinical, Clinical, Commercial
3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas
4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications
Subsegments:
1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services
2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Innovation Trends Driving Future Development
Key players in the market for messenger ribonucleic acid (mRNA) synthesis and manufacturing are prioritizing the development of advanced solutions, such as co-transcriptional capping platforms, to speed up preclinical research while minimizing regulatory hurdles. This platform represents a specialized technique that effectively attaches a protective cap to mRNA molecules during the synthesis process, resulting in improved mRNA stability, enhanced translation efficiency, and better control over immunogenicity. As an example, in May 2025, GenScript, a life sciences research tools company based in the US, introduced its good manufacturing practice (GMP)-like mRNA manufacturing service. This scalable service, designed with regulatory considerations in mind, produces high-purity, functional mRNA suitable for investigational new drug (IND)-enabling preclinical studies, covering toxicology, biodistribution, and pharmacokinetics or pharmacodynamics (PK or PD) evaluations. The service operates within cleanroom-compliant environments classified as International Organization for Standardization (ISO) 7 and integrates patented co-transcriptional capping technology, allowing for the delivery of customized mRNA within about seven weeks. This advancement effectively fills a critical gap between research-grade production and full GMP manufacturing, enabling early-stage biotechnology and pharmaceutical firms to conduct studies that meet regulatory standards without the substantial expenses and delays typically associated with traditional GMP processes.
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Key Players And Strategic Industry Positioning
Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC
Access The Complete Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report:
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Geographic Distribution And Regional Opportunities
North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
